Cargando…
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action
Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of building a global system that can support both routine and pandemic/epidemic adult immunization. As such, a framework to recommend vaccines and build robust platforms to deliver them to protect the rapidly expanding...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332930/ https://www.ncbi.nlm.nih.gov/pubmed/32703743 http://dx.doi.org/10.1016/j.vaccine.2020.06.082 |
_version_ | 1783553635675799552 |
---|---|
author | Privor-Dumm, Lois A. Poland, Gregory A. Barratt, Jane Durrheim, David N. Deloria Knoll, Maria Vasudevan, Prarthana Jit, Mark Bonvehí, Pablo E. Bonanni, Paolo |
author_facet | Privor-Dumm, Lois A. Poland, Gregory A. Barratt, Jane Durrheim, David N. Deloria Knoll, Maria Vasudevan, Prarthana Jit, Mark Bonvehí, Pablo E. Bonanni, Paolo |
author_sort | Privor-Dumm, Lois A. |
collection | PubMed |
description | Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of building a global system that can support both routine and pandemic/epidemic adult immunization. As such, a framework to recommend vaccines and build robust platforms to deliver them to protect the rapidly expanding demographic of older adults is needed. Adult immunization as a strategy has the broad potential to preserve and improve medical, social, and economic outcomes, including maintaining functional ability that benefits older adults, their families, communities, and countries. While we will soon have multiple vaccines against COVID-19, we must recognize that we already have a variety of vaccines against other pathogens that can keep adults healthier. They can prevent simultaneous co-infection with COVID-19, and may favorably impact- the outcome of a COVID-19 illness. Further, administering a vaccine against COVID-19 requires planning now to determine delivery strategies impacting how older adults will be immunized in a timely manner. A group of international experts with various backgrounds from health and aging disciplines met to discuss the evidence case for adult immunization and crucial knowledge gaps that must be filled in order to implement effective policies and programs for older adult immunization. This group, coming together as the International Council on Adult Immunization (ICAI), outlined a high-level roadmap to catalyze action, provide policy guidance, and envision a global adult immunization platform that can be adapted by countries to fit their local contexts. Further meetings centered around the value of adult immunization, particularly in the context of COVID-19. There was agreement that programs to deliver existing influenza, pneumococcal, herpes zoster vaccines, and future COVID-19 vaccines to over a billion older adults who are at substantially higher risk of death and disability due to vaccine-preventable diseases are more urgent than ever before. Here we present a proposed framework for delivering routine and pandemic vaccines. We call upon the global community and governments to prioritize action for integrating robust adult immunization programs into the public health agenda. |
format | Online Article Text |
id | pubmed-7332930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-73329302020-07-06 A global agenda for older adult immunization in the COVID-19 era: A roadmap for action Privor-Dumm, Lois A. Poland, Gregory A. Barratt, Jane Durrheim, David N. Deloria Knoll, Maria Vasudevan, Prarthana Jit, Mark Bonvehí, Pablo E. Bonanni, Paolo Vaccine Conference Report Given our global interconnectedness, the COVID-19 pandemic highlights the urgency of building a global system that can support both routine and pandemic/epidemic adult immunization. As such, a framework to recommend vaccines and build robust platforms to deliver them to protect the rapidly expanding demographic of older adults is needed. Adult immunization as a strategy has the broad potential to preserve and improve medical, social, and economic outcomes, including maintaining functional ability that benefits older adults, their families, communities, and countries. While we will soon have multiple vaccines against COVID-19, we must recognize that we already have a variety of vaccines against other pathogens that can keep adults healthier. They can prevent simultaneous co-infection with COVID-19, and may favorably impact- the outcome of a COVID-19 illness. Further, administering a vaccine against COVID-19 requires planning now to determine delivery strategies impacting how older adults will be immunized in a timely manner. A group of international experts with various backgrounds from health and aging disciplines met to discuss the evidence case for adult immunization and crucial knowledge gaps that must be filled in order to implement effective policies and programs for older adult immunization. This group, coming together as the International Council on Adult Immunization (ICAI), outlined a high-level roadmap to catalyze action, provide policy guidance, and envision a global adult immunization platform that can be adapted by countries to fit their local contexts. Further meetings centered around the value of adult immunization, particularly in the context of COVID-19. There was agreement that programs to deliver existing influenza, pneumococcal, herpes zoster vaccines, and future COVID-19 vaccines to over a billion older adults who are at substantially higher risk of death and disability due to vaccine-preventable diseases are more urgent than ever before. Here we present a proposed framework for delivering routine and pandemic vaccines. We call upon the global community and governments to prioritize action for integrating robust adult immunization programs into the public health agenda. Elsevier Science 2021-08-31 2020-07-03 /pmc/articles/PMC7332930/ /pubmed/32703743 http://dx.doi.org/10.1016/j.vaccine.2020.06.082 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Conference Report Privor-Dumm, Lois A. Poland, Gregory A. Barratt, Jane Durrheim, David N. Deloria Knoll, Maria Vasudevan, Prarthana Jit, Mark Bonvehí, Pablo E. Bonanni, Paolo A global agenda for older adult immunization in the COVID-19 era: A roadmap for action |
title | A global agenda for older adult immunization in the COVID-19 era: A roadmap for action |
title_full | A global agenda for older adult immunization in the COVID-19 era: A roadmap for action |
title_fullStr | A global agenda for older adult immunization in the COVID-19 era: A roadmap for action |
title_full_unstemmed | A global agenda for older adult immunization in the COVID-19 era: A roadmap for action |
title_short | A global agenda for older adult immunization in the COVID-19 era: A roadmap for action |
title_sort | global agenda for older adult immunization in the covid-19 era: a roadmap for action |
topic | Conference Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332930/ https://www.ncbi.nlm.nih.gov/pubmed/32703743 http://dx.doi.org/10.1016/j.vaccine.2020.06.082 |
work_keys_str_mv | AT privordummloisa aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT polandgregorya aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT barrattjane aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT durrheimdavidn aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT deloriaknollmaria aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT vasudevanprarthana aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT jitmark aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT bonvehipabloe aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT bonannipaolo aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT aglobalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT privordummloisa globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT polandgregorya globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT barrattjane globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT durrheimdavidn globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT deloriaknollmaria globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT vasudevanprarthana globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT jitmark globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT bonvehipabloe globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT bonannipaolo globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction AT globalagendaforolderadultimmunizationinthecovid19eraaroadmapforaction |